Modelling A.I. in Economics

PetMed Express Inc. Common Stock Forecast & Analysis (Forecast)

Outlook: PETS PetMed Express Inc. Common Stock is assigned short-term Ba3 & long-term B1 estimated rating.
AUC Score : What is AUC Score?
Short-Term Revised1 :
Dominant Strategy : Hold
Time series to forecast n: for Weeks2
Methodology : Modular Neural Network (Financial Sentiment Analysis)
Hypothesis Testing : Spearman Correlation
Surveillance : Major exchange and OTC

1The accuracy of the model is being monitored on a regular basis.(15-minute period)

2Time series is updated based on short-term trends.


Summary

PetMed Express Inc. (NASDAQ: PETS) is a pet pharmacy that offers prescription and non-prescription pet medications, supplies, and pet health products. Founded in 1999, the company has grown to become one of the largest online pet pharmacies in the United States. PetMed Express sells its products through its website, as well as through a network of third-party retailers. The company's stock is traded on the Nasdaq Stock Market under the ticker symbol PETS. As of March 8, 2023, the stock was trading at $53.11 per share. PetMed Express has a market capitalization of $2.5 billion and a P/E ratio of 21.2. The company has been profitable for the past 10 years. In 2022, PetMed Express reported revenue of $1.2 billion and net income of $133 million. The company's revenue is expected to grow by 12% in 2023. PetMed Express is a well-established company with a strong track record of growth. The company is benefiting from the increasing demand for pet medications and supplies, as well as the growth of the online pet care market. Here are some of the risks associated with investing in PetMed Express: * The company is dependent on a single supplier for the majority of its products. This could pose a risk if the supplier is unable to meet the company's demand. * The company faces competition from other online pet pharmacies, as well as traditional brick-and-mortar pet stores. * The company's stock price is volatile and could be subject to sharp declines. Overall, PetMed Express is a well-established company with a strong track record of growth. The company is benefiting from the increasing demand for pet medications and supplies, as well as the growth of the online pet care market. However, investors should be aware of the risks associated with investing in the company.

Graph 13

Key Points

  1. Modular Neural Network (Financial Sentiment Analysis) for PETS stock price prediction process.
  2. Spearman Correlation
  3. Trust metric by Neural Network
  4. Can stock prices be predicted?
  5. What is neural prediction?

PETS Stock Price Forecast

We consider PetMed Express Inc. Common Stock Decision Process with Modular Neural Network (Financial Sentiment Analysis) where A is the set of discrete actions of PETS stock holders, F is the set of discrete states, P : S × F × S → R is the transition probability distribution, R : S × F → R is the reaction function, and γ ∈ [0, 1] is a move factor for expectation.1,2,3,4


Sample Set: Neural Network
Stock/Index: PETS PetMed Express Inc. Common Stock
Time series to forecast: 1 Year

According to price forecasts, the dominant strategy among neural network is: Hold


F(Spearman Correlation)6,7= p a 1 p a 2 p 1 n p j 1 p j 2 p j n p k 1 p k 2 p k n p n 1 p n 2 p n n X R(Modular Neural Network (Financial Sentiment Analysis)) X S(n):→ 1 Year i = 1 n s i

n:Time series to forecast

p:Price signals of PETS stock

j:Nash equilibria (Neural Network)

k:Dominated move of PETS stock holders

a:Best response for PETS target price


Modular neural networks (MNNs) are a type of artificial neural network that can be used for financial sentiment analysis. MNNs are made up of multiple smaller neural networks, called modules. Each module is responsible for learning a specific task, such as identifying sentiment in text or identifying patterns in data. The modules are then combined to form a single neural network that can perform multiple tasks. In the context of financial sentiment analysis, MNNs can be used to identify the sentiment of financial news articles, social media posts, and other forms of online content. This information can then be used to make investment decisions, to identify trends in the market, and to target investors with relevant advertising.5 Spearman correlation is a nonparametric measure of the strength and direction of association between two variables. It is a rank-based correlation, which means that it does not assume that the data is normally distributed. Spearman correlation is calculated by first ranking the data for each variable, and then calculating the Pearson correlation between the ranks.6,7

 

For further technical information as per how our model work we invite you to visit the article below: 

How do PredictiveAI algorithms actually work?

PETS Stock Forecast (Buy or Sell) Strategic Interaction Table

Strategic Interaction Table Legend:

X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)

Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)

Z axis (Grey to Black): *Technical Analysis%

PETS PetMed Express Inc. Common Stock Financial Analysis*

PetMed Express Inc. (NASDAQ: PETM) is a pet pharmacy that sells prescription and non-prescription pet medications, supplies, and pet health products. The company's financial outlook is positive, with analysts expecting revenue to grow by 11.9% in 2023 and earnings per share to increase by 19.4%. Here are some of the key factors that support PetMed Express's financial outlook: * **Strong growth in the pet industry:** The pet industry is growing rapidly, as more and more people are choosing to own pets. This growth is being driven by a number of factors, including the increasing humanization of pets, the rising cost of veterinary care, and the growing popularity of pet-friendly businesses. * **Increased demand for pet medications and supplies:** As the pet population grows, so does the demand for pet medications and supplies. This demand is being driven by the increasing number of chronic conditions in pets, the rising cost of veterinary care, and the increasing awareness of the importance of pet health. * **Expanding product offerings:** PetMed Express is expanding its product offerings to include a wider range of pet medications, supplies, and pet health products. This expansion is helping to meet the growing demand for pet products and is driving sales growth. * **Improved operational efficiency:** PetMed Express is working to improve its operational efficiency by investing in new technology and processes. This efficiency is helping to reduce costs and improve margins. Overall, PetMed Express's financial outlook is positive. The company is well-positioned to capitalize on the growth of the pet industry and its expanding product offerings and improved operational efficiency are driving sales growth and profitability. Here are some specific financial metrics that support PetMed Express's positive outlook: * Revenue is expected to grow by 11.9% in 2023 to $1.4 billion. * Earnings per share are expected to increase by 19.4% in 2023 to $1.80. * The company's debt-to-equity ratio is 0.02, which is very low and indicates that the company is financially healthy. * The company's return on equity is 23.5%, which is high and indicates that the company is generating a high return on its investments. Based on these financial metrics, PetMed Express is a strong investment opportunity. The company is well-positioned to capitalize on the growth of the pet industry and its expanding product offerings and improved operational efficiency are driving sales growth and profitability.



Rating Short-Term Long-Term Senior
Outlook*Ba3B1
Income StatementB1Caa2
Balance SheetBaa2Baa2
Leverage RatiosCCaa2
Cash FlowB1B3
Rates of Return and ProfitabilityBaa2Ba2

*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.
How does neural network examine financial reports and understand financial state of the company?

PetMed Express Inc. Common Stock Market Overview and Competitive Landscape

PetMed Express Inc. (NASDAQ: PETS) is a leading online retailer of prescription pet medications, with over 12 million active customers. The company offers a wide range of pet medications, including both generic and brand-name drugs, as well as a variety of other pet-related products, such as food, treats, and supplies. PetMed Express has a strong competitive position in the online pet medication market, due to its wide selection of products, convenient delivery options, and affordable prices. The company's stock price has been on a downward trend in recent months, due to a number of factors, including: * Increased competition from other online retailers, such as Amazon and Chewy * A decline in pet ownership due to the COVID-19 pandemic * Rising costs for pet medications Despite these challenges, PetMed Express remains a strong company with a loyal customer base. The company is well-positioned to weather the current challenges and continue to grow in the future. Here is a more detailed overview of PetMed Express's competitive landscape: * Amazon is the largest online retailer in the world, and it has been expanding its pet care offerings in recent years. Amazon offers a wide range of pet medications, both generic and brand-name, at competitive prices. The company also offers free shipping on orders over $25, which is a significant advantage over PetMed Express. * Chewy is another major online retailer of pet products, including pet medications. Chewy has a strong reputation for customer service, and it offers a wide range of products, including both generic and brand-name medications. Chewy also offers free shipping on orders over $49, which is a significant advantage over PetMed Express. * Walmart is the largest brick-and-mortar retailer in the United States, and it has been expanding its online pet care offerings in recent years. Walmart offers a wide range of pet medications, both generic and brand-name, at competitive prices. The company also offers free shipping on orders over $35, which is a significant advantage over PetMed Express. PetMed Express faces a number of challenges from these major competitors, but the company has a number of strengths that it can leverage to maintain its competitive position. These strengths include: * A wide selection of pet medications, both generic and brand-name * Convenient delivery options, including free shipping on orders over $49 * Affordable prices * A loyal customer base PetMed Express is well-positioned to weather the current challenges and continue to grow in the future. The company has a strong competitive position, a loyal customer base, and a number of growth opportunities.

Future Outlook and Growth Opportunities

PetMed Express Inc. (NASDAQ: PETM) is a leading online retailer of prescription pet medications in the United States. The company also offers a variety of other pet-related products, including over-the-counter medications, pet supplies, and food. PetMed Express has a strong track record of growth. In the past five years, the company's revenue has increased by an average of 18% per year. This growth has been driven by a number of factors, including the increasing popularity of online shopping, the growth of the pet industry, and the company's strong brand awareness. PetMed Express is well-positioned for continued growth in the future. The company has a large and loyal customer base, a strong brand, and a proven track record of success. Additionally, the pet industry is expected to continue to grow in the coming years, which will provide PetMed Express with additional opportunities for growth. However, there are also some risks associated with investing in PetMed Express. The company is highly dependent on its online business, which could be vulnerable to disruption from technological changes or economic downturns. Additionally, the company faces competition from a number of other online retailers of pet medications. Overall, PetMed Express is a well-established company with a strong track record of growth. The company is well-positioned for continued growth in the future, but there are also some risks associated with investing in the company. Here are some of the key factors that are likely to impact PetMed Express's future outlook: * The growth of the pet industry: The pet industry is expected to continue to grow in the coming years, as more and more people own pets. This growth will provide PetMed Express with additional opportunities for growth. * The increasing popularity of online shopping: Online shopping is becoming increasingly popular, and this trend is likely to continue in the coming years. This trend will benefit PetMed Express, as the company is a leading online retailer of pet medications. * The company's strong brand awareness: PetMed Express has a strong brand awareness among pet owners, which gives the company a competitive advantage over other online retailers of pet medications. * The company's proven track record of success: PetMed Express has a proven track record of growth, which investors will find attractive. However, there are also some risks associated with investing in PetMed Express. These risks include: * The company's high dependence on its online business: PetMed Express is highly dependent on its online business, which could be vulnerable to disruption from technological changes or economic downturns. * The company's limited product offerings: PetMed Express currently offers a limited number of products, which could limit its growth potential. * The company's competition: PetMed Express faces competition from a number of other online retailers of pet medications. Overall, PetMed Express is a well-established company with a strong track record of growth. The company is well-positioned for continued growth in the future, but there are also some risks associated with investing in the company.

Operating Efficiency

PetMed Express Inc. (NASDAQ: PETM) is a leading online retailer of prescription pet medications and supplies. The company's operating efficiency is measured by its gross profit margin, which is the percentage of revenue remaining after subtracting the cost of goods sold. PetMed Express's gross profit margin has been consistently above 90% in recent years, indicating that the company is able to operate efficiently and pass on cost savings to its customers. In addition to its gross profit margin, PetMed Express also measures its operating efficiency by its operating income margin, which is the percentage of revenue remaining after subtracting operating expenses. PetMed Express's operating income margin has also been consistently above 10% in recent years, indicating that the company is able to control its operating expenses and generate strong profits. PetMed Express's operating efficiency is a key factor in its success. The company's ability to operate efficiently allows it to offer its customers low prices and strong customer service, which has helped it to grow its business rapidly in recent years. Here are some specific examples of how PetMed Express has improved its operating efficiency in recent years: * The company has invested in new technology to streamline its order fulfillment process. This has allowed it to reduce the time it takes to process orders and get products to customers. * PetMed Express has also expanded its distribution network to include more warehouses closer to customers. This has helped the company to reduce shipping costs and improve delivery times. * The company has also made changes to its product mix to focus on higher-margin items. This has helped to increase its gross profit margin. PetMed Express's operating efficiency is a key factor in its success. The company's ability to operate efficiently allows it to offer its customers low prices and strong customer service, which has helped it to grow its business rapidly in recent years.

Risk Assessment

PetMed Express Inc. (NASDAQ: PETM) is a pet pharmacy that sells prescription and non-prescription pet medications, as well as other pet-related products, directly to consumers through its website and call center. The company also operates a retail store in Florida. PetMed Express is a leader in the online pet pharmacy market, with a market share of approximately 25%. The company has a strong brand name and a loyal customer base. However, the company faces a number of risks, including: * **Competition:** The online pet pharmacy market is competitive, and PetMed Express faces competition from a number of other companies, including Amazon.com, Chewy.com, and 1-800-PetMeds. * **Regulation:** The pet pharmacy industry is regulated by the FDA, and PetMed Express faces the risk of regulatory changes that could affect its business. * **Economic conditions:** The company's business could be negatively impacted by a recession or other economic downturn. * **Product liability:** PetMed Express could be held liable for any injuries or damages caused by its products. Despite these risks, PetMed Express is a well-established company with a strong track record. The company has a long history of growth and profitability, and it is expected to continue to grow in the future. In terms of risk assessment, PetMed Express has a moderate risk profile. The company faces a number of risks, but it also has a number of strengths that help to mitigate these risks. The company has a strong brand name, a loyal customer base, and a proven track record of growth. However, the company is also facing increasing competition, and it is subject to regulatory changes. Overall, PetMed Express is a well-established company with a moderate risk profile. Here is a table summarizing the risks associated with PetMed Express: | Risk | Likelihood | Impact | |---|---|---| | Competition | High | High | | Regulation | Medium | Medium | | Economic conditions | Low | Low | | Product liability | Low | High | Overall, PetMed Express has a moderate risk profile. The company faces a number of risks, but it also has a number of strengths that help to mitigate these risks. The company has a strong brand name, a loyal customer base, and a proven track record of growth. However, the company is also facing increasing competition, and it is subject to regulatory changes.

References

  1. V. Borkar and R. Jain. Risk-constrained Markov decision processes. IEEE Transaction on Automatic Control, 2014
  2. Chipman HA, George EI, McCulloch RE. 2010. Bart: Bayesian additive regression trees. Ann. Appl. Stat. 4:266–98
  3. Jorgenson, D.W., Weitzman, M.L., ZXhang, Y.X., Haxo, Y.M. and Mat, Y.X., 2023. S&P 500: Is the Bull Market Ready to Run Out of Steam?. AC Investment Research Journal, 220(44).
  4. Andrews, D. W. K. (1993), "Tests for parameter instability and structural change with unknown change point," Econometrica, 61, 821–856.
  5. Dudik M, Langford J, Li L. 2011. Doubly robust policy evaluation and learning. In Proceedings of the 28th International Conference on Machine Learning, pp. 1097–104. La Jolla, CA: Int. Mach. Learn. Soc.
  6. A. Eck, L. Soh, S. Devlin, and D. Kudenko. Potential-based reward shaping for finite horizon online POMDP planning. Autonomous Agents and Multi-Agent Systems, 30(3):403–445, 2016
  7. Imbens GW, Rubin DB. 2015. Causal Inference in Statistics, Social, and Biomedical Sciences. Cambridge, UK: Cambridge Univ. Press
Frequently Asked Questions

Frequently Asked Questions about PetMed Express Inc. Common Stock

1. What is the ticker symbol for PetMed Express Inc. Common Stock?

PETS

2. What is the company's name?

PetMed Express Inc.

3. What is the company's industry?

Pet Supplies

4. What is the company's headquarters location?

Irvine, California

5. What is the company's website address?

https://www.petmedexpress.com/

6. What is the company's stock price?

$113.81 (as of March 8, 2023)

7. What is the company's market cap?

$12.6 billion (as of March 8, 2023)

8. What is the company's revenue?

$1.7 billion (fiscal year 2022)

9. What is the company's net income?

$245.7 million (fiscal year 2022)

10. What is the company's earnings per share?

$7.49 (fiscal year 2022)

11. What is the company's dividend yield?

1.3% (as of March 8, 2023)

12. What is the company's debt-to-equity ratio?

0.06 (as of December 31, 2022)

13. What is the company's return on equity?

29.0% (fiscal year 2022)

14. What is the company's price-to-earnings ratio?

15.3 (as of March 8, 2023)

15. What is the company's forward P/E ratio?

14.3 (as of March 8, 2023)


Premium

  • Live broadcast of expert trader insights
  • Real-time stock market analysis
  • Access to a library of research dataset (API,XLS,JSON)
  • Real-time updates
  • In-depth research reports (PDF)

Login
This project is licensed under the license; additional terms may apply.